Table 2 Maternal respiratory and medical support of COVID-19 infected hospitalized patients during the pre-delta and delta time periods
Total study Population N = 173 | Pre-Delta n = 71 (%) | Delta n = 102 (%) | p-value¶ | ||
|---|---|---|---|---|---|
Intensive Care Unit admission | 16/163 (9.8) | 3/61 (4.9) | 13/102 (12.7) | 0.172 | |
Respiratory Support requirement | |||||
None | 147 (85) | 68 (95.8) | 79 (77.5) | 0.001 | |
Need for supplemental O2 or CPAP | 18 (10.4) | 1 (1.4) | 17 (16.7) | ||
Ventilatory support | 8 (4.6) | 2 (2.8) | 6 (5.9) | ||
Extra Corporeal Membrane Oxygenation | 1/160 (0.6) | 1/59 (1.7) | 0 (0) | 0.369 | |
Medications | |||||
Chloroquine | 5 (2.9) | 3 (4.2) | 2 (2) | 0.402 | |
Antivirals* | 28 (16.2) | 4 (5.6) | 24 (23.5) | 0.001 | |
Monoclonal antibodies# | 3 (1.7) | 0 (0) | 3 (2.9) | 0.27 | |
Steroids for Fetal Indication | 19 (11) | 7 (9.9) | 12 (11.8) | 0.087 | |
Steroids for Maternal Indication | 26 (15) | 7 (9.9) | 19 (18.6) | 0.112 | |
Antibiotics | 33 (19.1) | 13 (18.3) | 20 (19.6) | 0.847 | |
Anticoagulants | 17 (9.8) | 3 (4.2) | 14 (13.7) | 0.042 | |
Other | 9 (5.2) | 3 (4.2) | 6 (5.9) | 0.739 | |